EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol

Fumika Karaki, Taro Takamori, Koumei Kawakami, Sae Sakurai, Kyoko Hidaka, Kei Ishii, Tomoya Oki, Noriko Sato, Nao Atsumi, Karin Ashizawa, Ai Taguchi, Asuka Ura und 6 weitere

Molecules · 2023

DOI: 10.3390/molecules28196925 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Molecules, 2023. Verfasst von Fumika Karaki und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8641, Japan. Hauptthemen laut MEDLINE: Receptors, Opioid, kappa, Copper. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kitasato University, JSPS KAKENHI, Kitasato University Research Grant for Young Researchers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In medicinal chemistry, the copper-catalyzed click reaction is used to prepare ligand candidates. This reaction is so clean that the bioactivities of the products can be determined without purification. Despite the advantages of this in situ screening protocol, the applicability of this method for transmembrane proteins has not been validated due to the incompatibility with copper catalysts. To address this point, we performed ligand screening for the µ, δ, and κ opioid receptors using this protocol. As we had previously reported the 7-azanorbornane skeleton as a privileged scaffold for the G protein-coupled receptors, we performed the click reactions between various 7-substituted 2-ethynyl-7-azanorbornanes and azides. Screening assays were performed without purification using the CellKeyTM system, and the putative hit compounds were re-synthesized and re-evaluated. Although the “hit” compounds for the µ and the δ receptors were totally inactive after purifications, three of the four “hits” for the κ receptor were true agonists for this receptor and also showed activities for the δ receptor. Although false positive/negative results exist as in other screening projects for soluble proteins, this in situ method is effective in identifying novel ligands for transmembrane proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Opioid, kappaCopperLigandsMembrane ProteinsReceptors, Opioid, muAnalgesics, Opioid

Stichwörter der Autor:innen

7-azanorbornaneG protein-coupled receptoraddictionanalgesicsclick reactiondual agonistin situ screeningopioid receptorpolypharmacology

Substanzen

Receptors, Opioid, kappaLigandsCopperMembrane ProteinsReceptors, Opioid, muAnalgesics, Opioid

Autor:innen und Institutionen

  • Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8641, Japan.
  • Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8641, Japan.
  • Analytical Unit for Organic Chemistry, Kitasato University, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8641, Japan.
  • Department of Pain Control Research, Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.

ORCID-Profile: Shigeto Hirayama, Miki Nonaka, Hideaki Fujii

Förderung

  • Kitasato University
  • JSPS KAKENHI
  • Kitasato University Research Grant for Young Researchers

Zitieren

APA

Karaki, F., Takamori, T., Kawakami, K., Sakurai, S., Hidaka, K., Ishii, K., Oki, T., Sato, N., Atsumi, N., Ashizawa, K., Taguchi, A., Ura, A., Naruse, T., Hirayama, S., Nonaka, M., Miyano, K., Uezono, Y., & Fujii, H. (2023). Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol. Molecules. https://doi.org/10.3390/molecules28196925

Vancouver

Karaki F, Takamori T, Kawakami K, Sakurai S, Hidaka K, Ishii K, et al. Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol. Molecules. 2023. doi:10.3390/molecules28196925

BibTeX
@article{Karaki2023,
  author = {Karaki, Fumika and Takamori, Taro and Kawakami, Koumei and Sakurai, Sae and Hidaka, Kyoko and Ishii, Kei and Oki, Tomoya and Sato, Noriko and Atsumi, Nao and Ashizawa, Karin and Taguchi, Ai and Ura, Asuka and Naruse, Toko and Hirayama, Shigeto and Nonaka, Miki and Miyano, Kanako and Uezono, Yasuhito and Fujii, Hideaki},
  title = {Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28196925}
}
Kostenlos starten →